pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
S.L clinical trials
Registry index of 18 ClinicalTrials.gov studies linked to S.L programs — each row shows trial ID, program name, phase, status, and indication.
S.L trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for S.L.
-
CBP-201-CN004 — Phase 1
Clinical update -
vitamin D3 — Phase 1
Clinical update -
umbilical cord blood (hUCB) cells — Phase 2
Clinical update -
Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] — Phase 1
Clinical update -
Acetaminophen — Phase 3
Clinical update -
CBP-201 — Phase 3
Clinical update -
CBP-201 — Phase 2
Clinical update -
CBP-201 — Phase 2
Clinical update